
Specialties
MGH Hotline 1.23.09 The MGH is a hub of scientific research and discovery, but translating these breakthroughs into commercial applications can be a challenging and sometimes confusing process.
A newly created consortium plans to change the future of vaccine research.
The Vaccine & Immunotherapy Center (VIC) at the MGH is committed to projects that accelerate vaccine and immunotherapy development, including those dedicated to finding improved treatment options for people with Type 1 diabetes, an autoimmune disease in which a person’s pancreas stops producing insulin.
Phone: 617-726-3906